<!-- Hier de html file waar je alles kan veranderen. 
Je kan de veranderingen die je maakt direct in de browser zien door deze file te openen in een browser. -->
<!doctype html>
<html>
<head>
    <!-- De title zie je in de tab van je browser, wordt ook gebruikt door google voor het zoeken van je website. -->
    <title>Cardiomyopathy risk calculator in childhood cancer survivors</title>
    <!-- De descriptie hier kan je ook veranderen, dit is alleen te zien door nerds en google -->
    <meta 
    name="description" 
    content="Calculator for cardiomyopathy risk prediction in childhood cancer survivors treated with anthracyclines and/or chest-directed radiotherapy."
    >
    <!-- zelfde voor de keywords -->
    <meta name="keywords" content="Heart failure, Cancer survivors, Jan Leerink">
    <meta name="author" content="Jan Leerink">
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css" integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm" crossorigin="anonymous">
    <link rel="stylesheet" href="style.css">
</head>

<body>
    <div class="container">
        <div class="row">
        <div class="col-md-6">
            <!-- Deze sectie is de titel die je ziet op de pagina en daarna de nummer input tabs -->
            <h1>Risk calculator for cardiomyopathy in childhood cancer survivors</h1>
              
            <!-- Hier komt de uitleg, h1 is de titel en p is de paragraaf. Je kan ook meer paragraven toevoegen -->
            <p>This calculator can be used in childhood cancer survivors to estimate the probability of cardiomyopathy within 10 years 
                from the surveillance echocardiogram at >5 years after cancer diagnosis.   
                Cardiomyopathy was defined as a left ventricular ejection fraction <40% during follow-up, 
                the treshold for pharmacological heart failure treatment initiation according to 
                the European Society of Cardiology heart failure guideline.
                The risk calculator was developed for adult >5-year childhood cancer survivors treated with anthracyclines and/or chest-directed radiotherapy
                without heart failure or a left ventricular ejection fraction <40% at time of the risk assessment.
                The prediction model to estimate the risk was developed and validated in the publication from Leerink et al. 2020 (REF..).
                </p>
                <p>To calculate the 10-year probability of cardiomyopathy, please fill in the 3 variables below:</p>
       
            <form>
                <div class="form-group">
                    <!-- Je kan hier de labels veranderen als je dat wil -->
                    <label for="EF">Left ventricular ejection fraction (%) at the surveillance echocardiogram >5 years after cancer diagnosis</label>
                    <input type="number" class="form-control" id="EF" min="40" max="70">
                </div>
                <div class="form-group">
                    <label for="ANT">Cumulative anthracycline dose (mg/m2)</label>
                    <input type="number" class="form-control" id="ANT" min="0" max="600">
                </div>
                <div class="form-group">
                    <label for="CHESTRT">Cumulative chest-directed radiotherapy dose (Gray)</label>
                    <input type="number" class="form-control" id="CHESTRT" min="0" max="50">
                </div>
                <div class="form-group">
                    <button type="button" class="btn btn-primary" onclick="getResult()">Calculate</button>
                </div>
            </form>
            <div class="hide" id="resultDiv">
                <!-- Hier kan je de tekst aanpassen met het resultaat -->
                <p>The 10-year probability for cardiomyopathy is <span id="results"></span>.</p>
                <p><b>Contact</b></p>
                <p>Jan Leerink</p>
                <p>Amsterdam UMC, location AMC and Princess Maxima Center for Pediatric Oncology</p>
                <p>j.m.leerink@amsterdamumc.nl</p>
            </div>
                
                
        </div>
        
        </div>
    </div>

    <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js" integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl" crossorigin="anonymous"></script>
    <script src="script.js"></script>
</body>
</html>
